当前位置: X-MOL 学术Eur. Gastroenterol. Hepatol. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Efficacy and safety of naldemedine for opioid-induced constipation in older patients with cancer: a retrospective study.
European Journal of Gastroenterology & Hepatology ( IF 2.1 ) Pub Date : 2024-03-04 , DOI: 10.1097/meg.0000000000002746
Hisao Imai 1, 2 , Yukiyoshi Fujita 3 , Eriko Hiruta 3 , Takashi Masuno 4 , Shigeki Yamazaki 5 , Hajime Tanaka 6 , Teruhiko Kamiya 7 , Mitsuru Sandoh 8 , Satoshi Takei 9 , Kazuya Arai 10 , Hiromi Nishiba 11, 12 , Junnosuke Mogi 13 , Shiro Koizuka 14 , Taeko Saito 3 , Kyoko Obayashi 12 , Kyoichi Kaira 1 , Koichi Minato 2
Affiliation  

Opioids are pain relievers that are often associated with opioid-induced constipation (OIC) that worsens with age. We performed a multicenter, retrospective analysis on the efficacy and safety of naldemedine, an opioid receptor antagonist, in treating OIC in patients with cancer (age >75 years).

中文翻译:

纳尔德米定治疗老年癌症患者阿片类药物引起的便秘的疗效和安全性:一项回顾性研究。

阿片类药物是止痛药,通常与阿片类药物引起的便秘 (OIC) 有关,便秘会随着年龄的增长而恶化。我们对阿片受体拮抗剂纳尔德米定治疗癌症患者(年龄 >75 岁)OIC 的有效性和安全性进行了多中心回顾性分析。
更新日期:2024-03-04
down
wechat
bug